Modified C-reactive protein interacts with platelet glycoprotein Ibα

Pharmacological Reports

Volumn 63, Issue 2, 2011, Pages 464-475

  Boncler, Magdalena ^a   Rywaniak, Joanna ^a   Szymański, Jacek ^a   Potempa, Lawrence A ^b   Rychlik, Błazej ^c   Watała, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Acphazin Inc ^*  (United States)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

Adhesion; Aggregation; C reactive protein; Glycoprotein Ib ; Platelet activation; Procoagulant activity; Surface plasmon resonance

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLYCOPROTEIN IB ALPHA; LIPOCORTIN 5;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEGRANULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 79955933206     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70513-8     Document Type: Article

References (52)

1. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C: A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem, 1994, 216, 444-450. (Pubitemid 24076032)
2. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW: The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J Exp Med, 1999, 190, 585-590. (Pubitemid 29395386)
3. Bisoendial RJ, Kastelein JJ, Stroes ES: C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis, 2007, 195, e10-e18. (Pubitemid 350087968)
4. Boguslawski G, McGlynn PW, Potempa LA, Filep JG, Labarrere CA: Conduct unbecoming: C-reactive protein interactions with a broad range of protein molecules. J Heart Lung Transplant, 2007, 26, 705-713. (Pubitemid 47001707)
5. Boncler M, Luzak B, Rozalski M, Golanski J, Rychlik B, Watala C: Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. Thromb Res, 2006, 119, 209-216.
6. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 1962, 194, 927-929.
7. 3. J Thromb Haemost, 2008, 6, 1239-1241.
8. Calabro P, Willerson JT, Yeh ET: Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation, 2003, 108, 1930-1932. (Pubitemid 37296536)
9. Christner RB, Mortensen RF: Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein. J Biol Chem, 1994, 269, 9760-9766.
10. Ciubotaru I, Potempa LA, Wander RC: Production of modified C-reactive protein in U937-derived macrophages. Exp Biol Med (Maywood), 2005, 230, 762-770. (Pubitemid 41565946)
11. Clemetson KJ. A short history of platelet glycoprotein Ib complex. Thromb Haemost, 2007, 98, 63-68.
12. Crowell RE, Du Clos TW, Montoya G, Heaphy E, Mold C: C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fcγ RI. J Immunol, 1991, 147, 3445-3451.
13. Devaraj S, Du Clos TW, Jialal I: Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol, 2005, 25, 1359-1363. (Pubitemid 40923352)
14. Diehl EE, Haines GK, III, Radosevich JA, Potempa LA: Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am J Med Sci, 2000, 319, 79-83. (Pubitemid 30349650)
15. Du Clos TW: C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum, 2003, 48, 1475-1477.
16. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H et al.: Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res, 2009, 105, 128-137.
17. Eriksson AC, Whiss PA: Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods, 2005, 52, 356-365. (Pubitemid 41526981)
18. Fiedel BA, Simpson RM, Gewurz H: Activation of platelets by modified C-reactive protein. Immunology, 1982, 45, 439-447. (Pubitemid 12165608)
19. Filep JG, Herman F, Kelemen E, Foldes-Filep E: C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res, 1991, 61, 411-421.
20. Gewurz H, Mold C, Siegel J, Fiedel B: C-reactive protein and the acute phase response. Adv Intern Med, 1982, 27, 345-372.
21. Hurlimann J, Thorbecke GJ, Hochwald GM: The liver as the site of C-reactive protein formation. J Exp Med, 1966, 123, 365-378.
22. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J: The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol, 2003, 33, 152-161. (Pubitemid 36157653)
23. Ji SR, Ma L, Bai CJ, Shi JM, Li HY, Potempa LA, Filep JG et al.: Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J, 2009, 23, 1806-1816.
24. Ji SR, Wu Y, Potempa LA, Qiu Q, Zhao J: Interactions of C-reactive protein with low-density lipoproteins: Implications for an active role of modified C-reactive protein in atherosclerosis. Int J Biochem Cell Biol, 2005, 38, 648-661. (Pubitemid 43117588)
25. Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL, Lu W, Zhao J: Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J, 2007, 21, 284-294.
26. Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG: Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem, 2002, 277, 40775-40781. (Pubitemid 35215662)
27. Khreiss T, Jozsef L, Potempa LA, Filep JG: Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation, 2004, 109, 2016-2022. (Pubitemid 38544493)
28. Khreiss T, Jozsef L, Potempa LA, Filep JG: Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation, 2004, 110, 2713-2720. (Pubitemid 39453024)
29. Kresl JJ, Potempa LA, Anderson B, Radosevich JA: Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein. Tumour Biol, 1999, 20, 72-87. (Pubitemid 29130693)
30. Kresl JJ, Potempa LA, Anderson BE: Conversion of native oligomeric to a modified monomeric form of human C-reactive protein. Int J Biochem Cell Biol, 1998, 30, 1415-1426. (Pubitemid 129750174)
31. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW: C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol, 1995, 155, 2185-2193.
32. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS: Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood, 1991, 77, 770-779.
33. Molins B, Pena E, Vilahur G, Mendieta C, Slevin M, Badimon L: C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol, 2008, 28, 2239-2246.
34. Motie M, Brockmeier S, Potempa LA: Binding of model soluble immune complexes to modified C-reactive protein. J Immunol, 1996, 156, 4435-4441. (Pubitemid 26165845)
35. Nocun M, Golanski J, Lapshina E, Zavodnik L, Dobaczewski M, Kazmierczak P, Markuszewski L et al.: Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness - a multiparametric study in rats. Clin Chem Lab Med, 2006, 44, 853-862.
36. Nurden P: Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension. Thromb Haemost, 1997, 78, 1305-1315.
37. Osmand AP, Friedenson B, Gewurz H, Painter RH, Hofmann T, Shelton E: Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci USA, 1977, 74, 739-743.
38. Pepys MB: C-reactive protein fifty years on. Lancet, 1981, 1, 653-657.
39. Potempa LA, Maldonado BA, Laurent P, Zemel ES, Gewurz H: Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol Immunol, 1983, 20, 1165-1175. (Pubitemid 14230026)
40. Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H: Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol Immunol, 1987, 24, 531-541. (Pubitemid 17062643)
41. Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H: Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation, 1988, 12, 391-405.
42. Ramage L, Proudfoot L, Guy K: Expression of Creactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles. Inhal Toxicol, 2004, 16, 607-613. (Pubitemid 38988742)
43. Salonen EM, Vartio T, Hedman K, Vaheri A: Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem, 1984, 259, 1496-1501. (Pubitemid 14104199)
44. Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA: C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis, 2006, 47, 212-222. (Pubitemid 43121324)
45. Schwedler SB, Guderian F, Dammrich J, Potempa LA, Wanner C: Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol Dial Transplant, 2003, 18, 2300-2307. (Pubitemid 37336817)
46. Simpson RM, Prancan A, Izzi JM, Fiedel BA: Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. Immunology, 1982, 47, 193-202. (Pubitemid 12015220)
47. Singh SK, Suresh MV, Voleti B, Agrawal A: The connection between C-reactive protein and atherosclerosis. Ann Med, 2008, 40, 110-120. (Pubitemid 351640645)
48. Walkowiak B, Kralisz U, Michalec L, Majewska E, Koziołkiewicz W, Ligocka A, Cierniewski CS: Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res, 2000, 99, 495-502.
49. Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS : Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res, 1989, 56, 763-766. (Pubitemid 20027441)
50. Watala C, Boncler M, Golanski J, Koziolkiewicz W, Walkowiak B, Cierniewski CS: Release of calcium and P-selectin from intraplatelet granules is hampered by procaine. Thromb Res, 1999, 94, 1-11. (Pubitemid 29170395)
51. Yasojima K, Schwab C, McGeer EG, McGeer PL: Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res, 2000, 887, 80-89. (Pubitemid 32008026)
52. Zouki C, Haas B, Chan JS, Potempa LA, Filep JG: Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion. J Immunol, 2001, 167, 5355-5361. (Pubitemid 33009775)